These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 8270337)
1. Leishmaniasis recidiva cutis in American cutaneous leishmaniasis. Bittencourt AL; Costa JM; Carvalho EM; Barral A Int J Dermatol; 1993 Nov; 32(11):802-5. PubMed ID: 8270337 [TBL] [Abstract][Full Text] [Related]
2. Atypical clinical variants in New World cutaneous leishmaniasis: disseminated, erysipeloid, and recidiva cutis due to Leishmania (V.) panamensis. Calvopina M; Gomez EA; Uezato H; Kato H; Nonaka S; Hashiguchi Y Am J Trop Med Hyg; 2005 Aug; 73(2):281-4. PubMed ID: 16103590 [TBL] [Abstract][Full Text] [Related]
3. Clinical and immunopathological aspects of disseminated cutaneous leishmaniasis. Carvalho EM; Barral A; Costa JM; Bittencourt A; Marsden P Acta Trop; 1994 Apr; 56(4):315-25. PubMed ID: 8023755 [TBL] [Abstract][Full Text] [Related]
4. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure. Coutinho SG; Oliveira MP; Da-Cruz AM; De Luca PM; Mendonça SC; Bertho AL; Soong L; McMahon-Pratt D Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764 [TBL] [Abstract][Full Text] [Related]
5. Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil. Romero GA; de la Glória Orge Orge M; de Farias Guerra MV; Paes MG; de Oliveira Macêdo V; de Carvalho EM Acta Trop; 2005 Jan; 93(1):49-56. PubMed ID: 15589797 [TBL] [Abstract][Full Text] [Related]
6. Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World. Salay G; Dorta ML; Santos NM; Mortara RA; Brodskyn C; Oliveira CI; Barbiéri CL; Rodrigues MM Clin Vaccine Immunol; 2007 Sep; 14(9):1173-81. PubMed ID: 17626159 [TBL] [Abstract][Full Text] [Related]
7. Leishmaniasis recidiva cutis in New World cutaneous leishmaniasis. Oliveira-Neto MP; Mattos M; Souza CS; Fernandes O; Pirmez C Int J Dermatol; 1998 Nov; 37(11):846-9. PubMed ID: 9865872 [TBL] [Abstract][Full Text] [Related]
8. Toll-like receptors 2, 4, and 9 expressions over the entire clinical and immunopathological spectrum of American cutaneous leishmaniasis due to Leishmania(V.) braziliensis and Leishmania (L.) amazonensis. Campos MB; Lima LVDR; de Lima ACS; Vasconcelos Dos Santos T; Ramos PKS; Gomes CMC; Silveira FT PLoS One; 2018; 13(3):e0194383. PubMed ID: 29543867 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the immune response in subjects with self-healing cutaneous leishmaniasis. Carvalho EM; Correia Filho D; Bacellar O; Almeida RP; Lessa H; Rocha H Am J Trop Med Hyg; 1995 Sep; 53(3):273-7. PubMed ID: 7573712 [TBL] [Abstract][Full Text] [Related]
10. Presence of parasite DNA in clinically unaffected nasal mucosa during cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis. Canário A; Queiroz M; Cunha G; Cavalcante T; Riesz V; Sharma R; de Noronha A; Correia T; Barral-Netto M; Barral A; Khouri R; Boaventura V Clin Microbiol Infect; 2019 Apr; 25(4):515.e5-515.e7. PubMed ID: 30616010 [TBL] [Abstract][Full Text] [Related]
11. CD4(+) T cells defined by their Vβ T cell receptor expression are associated with immunoregulatory profiles and lesion size in human leishmaniasis. Keesen TS; Antonelli LR; Faria DR; Guimarães LH; Bacellar O; Carvalho EM; Dutra WO; Gollob KJ Clin Exp Immunol; 2011 Sep; 165(3):338-51. PubMed ID: 21726211 [TBL] [Abstract][Full Text] [Related]
12. Parasitological and immunological follow-up of American tegumentary leishmaniasis patients. Coutinho SG; Pirmez C; Da-Cruz AM Trans R Soc Trop Med Hyg; 2002 Apr; 96 Suppl 1():S173-8. PubMed ID: 12055834 [TBL] [Abstract][Full Text] [Related]
13. Leishmania (V.) braziliensis: detection by PCR in biopsies from patients with cutaneous leishmaniasis. Gomes AH; Armelin IM; Menon SZ; Pereira-Chioccola VL Exp Parasitol; 2008 Jul; 119(3):319-24. PubMed ID: 18442815 [TBL] [Abstract][Full Text] [Related]
14. Cutaneous scars in American tegumentary leishmaniasis patients: a site of Leishmania (Viannia) braziliensis persistence and viability eleven years after antimonial therapy and clinical cure. Schubach A; Marzochi MC; Cuzzi-Maya T; Oliveira AV; Araujo ML; Oliveira AL; Pacheco RS; Momen H; Conceicao-Silva F; Coutinho SG; Marzochi KB Am J Trop Med Hyg; 1998 Jun; 58(6):824-7. PubMed ID: 9660473 [TBL] [Abstract][Full Text] [Related]
15. Characterization of regulatory T cell (Treg) function in patients infected with Leishmania braziliensis. Costa DL; Guimarães LH; Cardoso TM; Queiroz A; Lago E; Roselino AM; Bacellar O; Carvalho EM; Silva JS Hum Immunol; 2013 Dec; 74(12):1491-500. PubMed ID: 23993989 [TBL] [Abstract][Full Text] [Related]
16. The relationship of Leishmania braziliensis subspecies and immune response to disease expression in New World leishmaniasis. Saravia NG; Valderrama L; Labrada M; Holguín AF; Navas C; Palma G; Weigle KA J Infect Dis; 1989 Apr; 159(4):725-35. PubMed ID: 2647862 [TBL] [Abstract][Full Text] [Related]
17. Bubonic leishmaniasis: a common manifestation of Leishmania (Viannia) braziliensis infection in Ceara, Brazil. Sousa Ade Q; Parise ME; Pompeu MM; Coehlo Filho JM; Vasconcelos IA; Lima JW; Oliveira EG; Vasconcelos AW; David JR; Maguire JH Am J Trop Med Hyg; 1995 Oct; 53(4):380-5. PubMed ID: 7485690 [TBL] [Abstract][Full Text] [Related]
18. Impaired Th1 Response Is Associated With Therapeutic Failure in Patients With Cutaneous Leishmaniasis Caused by Leishmania braziliensis. Carvalho AM; Guimarães LH; Costa R; Saldanha MG; Prates I; Carvalho LP; Arruda S; Carvalho EM J Infect Dis; 2021 Feb; 223(3):527-535. PubMed ID: 32620011 [TBL] [Abstract][Full Text] [Related]
19. Golden hamster (Mesocricetus auratus) as an experimental model for Leishmania (Viannia) braziliensis infection. Gomes-Silva A; Valverde JG; Ribeiro-Romão RP; Plácido-Pereira RM; Da-Cruz AM Parasitology; 2013 May; 140(6):771-9. PubMed ID: 23369503 [TBL] [Abstract][Full Text] [Related]
20. Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis. Silveira FT; Lainson R; De Castro Gomes CM; Laurenti MD; Corbett CE Parasite Immunol; 2009 Aug; 31(8):423-31. PubMed ID: 19646206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]